Barber et al. just published a fundamentally flawed study on diabetes medicines in JAMA Network Open (JNO). This study wrongly suggests that cost-based pricing accurately values innovative on-patent ...

CVS is the latest pharmacy to change its drug pricing formula, a move it said would increase transparency and simplify costs. The company will now base drug costs on the amount that it pays for a drug ...

Case in point: The U.S. Securities and Exchange Commission (SEC) is operated as an independent federal agency, and its annual costs are paid for using transaction-based fees called Section 31 fees.